07:00 , May 21, 2001 |  BC Week In Review  |  Clinical News

Atragen tretinoin: Phase I data; Phase II

In a 17-patient U.S. Phase I trial of Atragen in combination with interferon alpha, 2 of 16 evaluable patients who received 15 mg/m 2 dosages of Atragen showed partial remission in bone and lung metastases...
07:00 , May 30, 2000 |  BC Week In Review  |  Clinical News

Atragen tretinoin: Phase I/II

In ARNX's Phase I/II dose escalation trial of Atragen in combination with interferon alpha, 2 of 3 patients had partial remissions. The trial was started using doses of 90 mg/m2 Atragen every other day plus...
07:00 , May 30, 2000 |  BC Week In Review  |  Clinical News

Atragen tretinoin: Phase I/II

In ARNX’s Phase I/II dose escalation trial of Atragen in combination with interferon alpha, 2 of 3 patients had partial remissions. The trial was started using doses of 90 mg/m 2 Atragen every other day...